Comparative characteristics of factors of cardiovascular risk in patients with arterial hypertension, depending on the type of endured vascular events (myocardial infarction / stroke)
Abstract
Objective: to establish the prevalence of the factors of cardiovascular risk (CR) in patients with arterial hypertension according to a history of vascular events (myocardial infarction (MI) / stroke). A cohort clinical study included 60 hypertensive patients aged 59,2±9 years. The group 1 included 20 patients endured myocardial infarction, group 2 - 21 patients who had stroke, 3 group - 19 patients had an arterial hypertension without a history of vascular events. In addition to general clinical examination an analysis of medical records and questioning of patients to determine factors СR have been carried out. Among the patients with hypertension and MI the proportion of men is (80% vs. 20%, p=0,05), the percentage of smokers - (65% vs. 48%, p=0,054), the proportion of patients with diabetes - (40% vs. 24%, p=0,026), the share of patients with high level of stress (30% vs. 19%, p=0,049) was higher, compared to the patients with stroke. Patients with hypertension and stroke, have a higher degree of hypertension (80% vs. 60% of patients with grade III hypertension, p=0,036) as compared with the patients after MI; they are older (62,5±10 years vs. 56,1±10, p=0,039), have a very low fidelity to hypotensive therapy (14% vs. 42% of patients with high fidelity, p=0,05) compared to the patients with hypertension without vascular events in the history. The reasons for the continuing high total СR in patients with hypertension are: inadequate control of total cholesterol and inadequate fidelity to hypotensive therapy.
References
2. Дзизинский А.А., Шпрах В.В., Синьков А.В. и др. Прогнозирование риска развития инфаркта миокарда и мозгового инсульта у больных артериальной гипертензией // Сибирский медицинский журнал (Иркутск). – 2010. – №6. – С. 25-27.
3. Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр) // Системные гипертензии. – 2010. – №3. – С. 5-26.
4. Европейские клинические рекомендации по профилактике сердечно-сосудистых заболеваний (пересмотр 2012 г.) // Российский кардиологический журнал. – 2012. – №4(96). Прил. 2. – 84 с.
5. Люсов В.А., Евсиков Е.М., Николаева Э.И. и др. Основные факторы патогенеза артериальной гипертензии у больных с наследственной отягощенностью // Российский кардиологический журнал. – 2007. – №1. – С. 6-15.
6. Мамедов М.Н., Дидигова Р.Т., Булгачева З.З. Оценка психологического статуса пациентов со стенокардией напряжения // Кардиология. – 2012. – Т. 52, №1. – С. 20-25.
7. Мамедов М.Н., Чепурина Н.А. Суммарный сердечно-сосудистый риск: от теории к практике: пособие для врачей / Под ред. Р. Г. Оганова. – М., 2007. – 23 с.
8. Попелышева А.Э., Калягин А.Н., Родиков М.В., Лебедева П.В. Артериальное давление как фактор риска развития и тяжести течения ишемического инсульта // Успехи современного естествознания. – 2011. - № 11. – С. 108.
9. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. – М.: Медиасфера. – 2003. – 305 с.
10. Рекомендации по лечению артериальной гипертонии. ESH/ESC 2013 // Российский кардиологический журнал. – 2014. – №1(105) – С. 7-94 с.
11. Усачева Е.В., Бунова С.С., Зуева И.М. и др. Значение оценки массы тела, как одного из факторов сердечно-сосудистого риска, у пациентов, перенесших инфаркт миокарда // Кардиоваскулярная терапия и профилактика. – 2013. – Т.12, №6. – С. 9-14.
12. Юренева С.В., Ильина Л.М. Предикторы сердечно-сосудистого риска у женщин: роль половых гормонов и образа жизни // Эффективная фармакотерапия. Эндокринология. – 2013. – №6. – С. 14-24.
13. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence // Med. Care. – 1986. – Vol. 24. – P. 67-74.
References
1. Alekseeva L.A., Kravcova N.N., Shashina N.B., et al. Diagnosis of chronic kidney disease in patients with risk factors for cardiovascular complications observed in outpatient settings // Klinicheskaja Nefrologia. – 2014. – №6. – P. 28-31. (in Russian)
2. Dzizinskij A.A., Sprakh V.V., Sinkov A.V., et al. Prognosis of risk of myocardial infarct and stroke in hypertensive patients // Siberskij medicinskij Zurnal (Irkutsk). – 2010. – №6. – P. 25-27. (in Russian)
3. Diagnosis and treatment of hypertension. Russian guidelines (4th revision) // Sistemnii Gipertenzii. – 2010. – №3. – P. 5-26. (in Russian)
4. European guidelines for the prevention of cardiovascular diseases (revision 2012) // Rossijskij Kardiologicheskij Zhurnal. – 2012 – №4 (96). Suppl. 2 – 84 p. (in Russian)
5. Lusov V.A., Evsikov E.M., Nikolaeva E.I., et al. Main pathogenetic factors of arterial hypertension in patients with compromised family history // Rossijskij Kardiologicheskij Zhurnal. – 2007. – №1. – P. 6-15. (in Russian)
6. Mamedov M.N., Didigova R.T., Bulgucheva Z.Z. Assessment of Psychological Status of Patients With Effort Angina // Kardiologia. – 2012. – Vol. 52, №1. – P. 20-25. (in Russian)
7. Mamedov M.N., Chepurina N.A. Total cardiovascular risk: from theory to practice: Manual for physicians / Ed. R.G. Oganov. – Moscow, 2007. – 23 p. (in Russian)
8. Popelysheva A.E., Kalyagin A.N., Rodikov M.V., Lebedev P.V. Blood pressure is a risk factor in the development and severity of ischemic stroke // Uspekhi Sovremennogo Estestvoznania. – 2011. - № 11. – P. 108. (in Russian)
9. Rebrova O.Y. Statistical analysis of medical data. The use of the application package STATISTICA. – Moscow: Media Sphere, 2003. – 305 p. (in Russian)
10. Recommendations for the treatment of hypertension. ESH / ESC 2013 // Rossijskij Kardiologicheskij Zhurnal. – 2014. – №1 (105). – P. 94. (in Russian)
11. Usacheva E.V., Bunova S.S., Zueva I.M., et al. Assessment of body weight, as one of the cardiovascular risk factors, in patients with myocardial infarction // Kardiovascularnaya Terapia i Profilaktika. – 2013. – V. 12, №6. – P. 9-14. (in Russian)
12. Yureneva S.V., Ilina L.M. Predictors of cardio-vascular risk in women: a role for sexual hormones and lifestyle // Effektivnaya Farmakoterapia. Endocrinologya. – 2013. – №6. – P. 14-24. (in Russian)
13. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence // Med. Care. – 1986. – Vol. 24. – P. 67-74.
